XML 51 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION (Notes)
6 Months Ended
Jun. 30, 2014
Guarantees [Abstract]  
Guarantor and Non-guarantor Financial Information [Text Block]
GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION
As discussed in Note 5, "Long-term Debt and Other Financing Arrangements", our 100% owned subsidiaries, CME NV and CME BV (collectively, the "Guarantor Subsidiaries"), have agreed to fully and unconditionally, and jointly and severally, guarantee (the “Guarantees”), the 2017 PIK Notes. The Guarantor Subsidiaries are subject to the requirements of Rule 3-10 of Regulation S-X regarding financial statements of guarantors and issuers of guaranteed securities registered or being registered with the SEC. Our remaining subsidiaries (the “Non-Guarantor Subsidiaries”) are presented separately from CME Ltd. (the “Parent Issuer”) and the Guarantor Subsidiaries in the condensed consolidating financial statements presented below.
The Guarantees are senior obligations of the Guarantors and rank equal in right of payment with all of the Guarantor Subsidiaries’ existing and future senior indebtedness, including in respect of their guarantees of the 2015 Convertible Notes, the 2017 Term Loan and the 2017 Revolving Credit Facility. In addition, the Guarantees rank senior in right of payment to any other existing and future obligations of the Guarantor Subsidiaries expressly subordinated in right of payment to the Guarantees. The Guarantees effectively rank junior to all of the future indebtedness and other liabilities of our Non-Guarantor Subsidiaries, including with respect to their obligations in respect of the 2017 PIK Notes.
CME Ltd. and the Guarantor Subsidiaries are holding companies with no revenue-generating operations and rely on the repayment of intercompany indebtedness and the declaration of dividends to receive distributions of cash from our operating subsidiaries and affiliates. There are no significant restrictions on CME Ltd.'s ability to obtain funds from the Guarantor Subsidiaries.
The following tables present condensed consolidating financial information relating to the Guarantor Subsidiaries as at June 30, 2014 and 2013, and for the three and six months ended June 30, 2014 and 2013:
Condensed Consolidating Balance Sheets as at June 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
9,522

 
$
841

 
$
77,461

 
$

 
$
87,824

Accounts receivable, net

 

 
190,699

 

 
190,699

Program rights, net

 

 
132,808

 

 
132,808

Other current assets
542

 
312

 
42,439

 

 
43,293

Assets held for sale

 

 
1,418

 

 
1,418

Intercompany current assets
18,905

 
884

 
49,854

 
(69,643
)
 

Total current assets
28,969

 
2,037

 
494,679

 
(69,643
)
 
456,042

Non-current assets
 
 
 
 
 
 
 
 
 
Investments in subsidiaries

 
545,072

 

 
(545,072
)
 

Property, plant and equipment, net

 

 
189,281

 

 
189,281

Program rights, net

 

 
260,411

 

 
260,411

Goodwill

 

 
777,147

 

 
777,147

Broadcast licenses and other intangible assets, net

 

 
215,171

 

 
215,171

Other non-current assets
52,534

 

 
10,550

 

 
63,084

Intercompany non-current assets
1,618,263

 
312,858

 
20,628

 
(1,951,749
)
 

Total non-current assets
1,670,797

 
857,930

 
1,473,188

 
(2,496,821
)
 
1,505,094

Total assets
$
1,699,766

 
$
859,967

 
$
1,967,867

 
$
(2,566,464
)
 
$
1,961,136

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
3,399

 
$
239

 
$
260,933

 
$

 
$
264,571

Current portion of long-term debt and other financing arrangements

 

 
1,479

 

 
1,479

Other current liabilities
469

 

 
41,217

 

 
41,686

Liabilities held for sale

 

 
1,418

 

 
1,418

Intercompany current liabilities
8,330

 
42,408

 
18,905

 
(69,643
)
 

Total current liabilities
12,198

 
42,647

 
323,952

 
(69,643
)
 
309,154

Non-current liabilities
 

 
 

 
 
 
 
 
 
Deficiency in excess of investments in subsidiaries

95,853

 

 

 
(95,853
)
 

Long-term debt and other financing arrangements
487,493

 

 
338,784

 

 
826,277

Other non-current liabilities
9,833

 

 
34,890

 

 
44,723

Intercompany non-current liabilities
313,407

 
1,638,342

 

 
(1,951,749
)
 

Total non-current liabilities
906,586

 
1,638,342

 
373,674

 
(2,047,602
)
 
871,000

Temporary equity
215,693

 

 

 

 
215,693

Total equity / (deficit)
565,289

 
(821,022
)
 
1,270,241

 
(449,219
)
 
565,289

Total liabilities and equity
$
1,699,766

 
$
859,967

 
$
1,967,867

 
$
(2,566,464
)
 
$
1,961,136


Condensed Consolidating Balance Sheets as at December 31, 2013    
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
19,461

 
$
5,422

 
$
78,741

 
$

 
$
103,624

Accounts receivable, net

 

 
174,081

 

 
174,081

Program rights, net

 

 
109,238

 

 
109,238

Other current assets
2,638

 
31

 
42,513

 

 
45,182

Assets held for sale

 

 
22,661

 

 
22,661

Intercompany current assets
53,396

 
2,052

 

 
(55,448
)
 

Total current assets
75,495

 
7,505

 
427,234

 
(55,448
)
 
454,786

Non-current assets
 

 
 

 
 
 
 
 
 
Investments in subsidiaries

 
479,435

 

 
(479,435
)
 

Property, plant and equipment, net

 

 
198,292

 

 
198,292

Program rights, net

 

 
288,344

 

 
288,344

Goodwill

 

 
782,870

 

 
782,870

Broadcast licenses and other intangible assets, net

 

 
223,815

 

 
223,815

Other non-current assets
3,976

 

 
9,790

 

 
13,766

Intercompany non-current assets
1,822,966

 
315,017

 
18,887

 
(2,156,870
)
 

Total non-current assets
1,826,942

 
794,452

 
1,521,998

 
(2,636,305
)
 
1,507,087

Total assets
$
1,902,437

 
$
801,957

 
$
1,949,232

 
$
(2,691,753
)
 
$
1,961,873

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
18,234

 
$
41

 
$
272,102

 
$

 
$
290,377

Current portion of long-term debt and other financing arrangements

 
71

 
2,040

 

 
2,111

Other current liabilities
500

 

 
16,129

 

 
16,629

Liabilities held for sale

 

 
7,105

 

 
7,105

Intercompany current liabilities
7,788

 
45,988

 
1,672

 
(55,448
)
 

Total current liabilities
26,522

 
46,100

 
299,048

 
(55,448
)
 
316,222

Non-current liabilities
 

 
 

 
 
 
 
 
 
Deficiency in excess of investments in subsidiaries
296,351

 

 

 
(296,351
)
 

Long-term debt and other financing arrangements
620,375

 

 
342,568

 

 
962,943

Other non-current liabilities

 

 
33,817

 

 
33,817

Intercompany non-current liabilities
310,298

 
1,846,572

 

 
(2,156,870
)
 

Total non-current liabilities
1,227,024

 
1,846,572

 
376,385

 
(2,453,221
)
 
996,760

Temporary equity
207,890

 

 

 

 
207,890

Total equity / (deficit)
441,001

 
(1,090,715
)
 
1,273,799

 
(183,084
)
 
441,001

Total liabilities and equity
$
1,902,437

 
$
801,957

 
$
1,949,232

 
$
(2,691,753
)
 
$
1,961,873


Condensed Consolidating Statements of Operations for the three months ended June 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
204,870

 
$

 
$
204,870

Cost of revenues

 

 
135,689

 

 
135,689

Selling, general and administrative expenses
5,289

 
275

 
38,124

 

 
43,688

Restructuring costs

 

 
2,920

 

 
2,920

Operating (loss) / income
(5,289
)
 
(275
)
 
28,137

 

 
22,573

Interest income
34,537

 
7,058

 
145

 
(41,591
)
 
149

Interest expense
(38,217
)
 
(34,476
)
 
(7,996
)
 
41,591

 
(39,098
)
Loss on extinguishment of debt
(24,161
)
 

 

 

 
(24,161
)
Foreign currency exchange gain / (loss), net
784

 
(2,822
)
 
2,064

 

 
26

Change in fair value of derivatives
2,361

 
418

 
(418
)
 

 
2,361

Other expense

 

 
(1,775
)
 

 
(1,775
)
(Loss) / gain from continuing operations before tax and loss from investment in subsidiaries
(29,985
)
 
(30,097
)
 
20,157

 

 
(39,925
)
Credit / (provision) for income taxes

 
4,326

 
(6,813
)
 

 
(2,487
)
(Loss) / income from continuing operations before loss from investment in subsidiaries
(29,985
)
 
(25,771
)
 
13,344

 

 
(42,412
)
Loss from investment in subsidiaries
(30,825
)
 
(5,054
)
 

 
35,879

 

(Loss) / income from continuing operations
(60,810
)
 
(30,825
)
 
13,344

 
35,879

 
(42,412
)
Loss from discontinued operations, net of tax

 

 
(10,095
)
 

 
(10,095
)
Net (loss) / income
(60,810
)
 
(30,825
)
 
3,249

 
35,879

 
(52,507
)
Net loss attributable to noncontrolling interests

 

 
69

 

 
69

Net (loss) / income attributable to CME Ltd.
(60,810
)
 
(30,825
)
 
3,318

 
35,879

 
(52,438
)
Comprehensive loss attributable to CME Ltd.
$
(60,810
)
 
$
(30,825
)
 
$
(5,054
)
 
$
35,879

 
$
(60,810
)

Condensed Consolidating Statements of Operations for the six months ended June 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
356,107

 
$

 
$
356,107

Cost of revenues

 

 
263,729

 

 
263,729

Selling, general and administrative expenses
8,956

 
527

 
66,346

 

 
75,829

Restructuring costs

 

 
8,286

 

 
8,286

Operating (loss) / income
(8,956
)
 
(527
)
 
17,746

 

 
8,263

Interest income
73,728

 
14,105

 
281

 
(87,819
)
 
295

Interest expense
(64,624
)
 
(73,606
)
 
(16,598
)
 
87,819

 
(67,009
)
Loss on extinguishment of debt
(24,161
)
 

 

 

 
(24,161
)
Foreign currency exchange gain / (loss), net
962

 
(3,722
)
 
2,368

 

 
(392
)
Change in fair value of derivatives
2,311

 
(2,429
)
 
2,429

 

 
2,311

Other expense

 

 
(1,768
)
 

 
(1,768
)
(Loss) / gain from continuing operations before tax and loss from investment in subsidiaries
(20,740
)
 
(66,179
)
 
4,458

 

 
(82,461
)
Credit / (provision) for income taxes

 
7,929

 
(8,219
)
 

 
(290
)
Loss from continuing operations before loss from investment in subsidiaries
(20,740
)
 
(58,250
)
 
(3,761
)
 

 
(82,751
)
Loss from investment in subsidiaries
(86,611
)
 
(28,548
)
 

 
115,159

 

Loss from continuing operations
(107,351
)
 
(86,798
)
 
(3,761
)
 
115,159

 
(82,751
)
Loss from discontinued operations, net of tax

 

 
(18,388
)
 

 
(18,388
)
Net loss
(107,351
)
 
(86,798
)
 
(22,149
)
 
115,159

 
(101,139
)
Net loss attributable to noncontrolling interests

 

 
786

 

 
786

Net loss attributable to CME Ltd.
(107,351
)
 
(86,798
)
 
(21,363
)
 
115,159

 
(100,353
)
Comprehensive loss attributable to CME Ltd.
$
(107,351
)
 
$
(86,611
)
 
$
(28,548
)
 
$
115,159

 
$
(107,351
)

Condensed Consolidating Statements of Operations for the three months ended June 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
175,566

 
$

 
$
175,566

Cost of revenues

 

 
141,303

 

 
141,303

Selling, general and administrative expenses
6,114

 
980

 
27,067

 

 
34,161

Restructuring costs

 

 
4,698

 

 
4,698

Operating (loss) / income
(6,114
)
 
(980
)
 
2,498

 

 
(4,596
)
Interest income
31,749

 
799

 
178

 
(32,546
)
 
180

Interest expense
(24,645
)
 
(28,274
)
 
(10,806
)
 
32,546

 
(31,179
)
Loss on extinguishment of debt
(23,115
)
 

 

 

 
(23,115
)
Foreign currency exchange gain / (loss), net
17,186

 
1,218

 
(3,357
)
 

 
15,047

Other income / (expense)

 
38

 
(450
)
 

 
(412
)
Loss from continuing operations before tax and loss on investment in subsidiaries
(4,939
)
 
(27,199
)
 
(11,937
)
 

 
(44,075
)
Credit for income taxes

 
1,797

 
1,535

 

 
3,332

Loss from continuing operations before loss on investment in subsidiaries
(4,939
)
 
(25,402
)
 
(10,402
)
 

 
(40,743
)
Loss on investment in subsidiaries
(47,333
)
 
(21,934
)
 

 
69,267

 

Loss from continuing operations
(52,272
)
 
(47,336
)
 
(10,402
)
 
69,267

 
(40,743
)
Loss from discontinued operations, net of tax

 

 
(350
)
 

 
(350
)
Net loss
(52,272
)
 
(47,336
)
 
(10,752
)
 
69,267

 
(41,093
)
Net loss attributable to noncontrolling interests

 

 
131

 

 
131

Net loss attributable to CME Ltd.
(52,272
)
 
(47,336
)
 
(10,621
)
 
69,267

 
(40,962
)
Comprehensive loss attributable to CME Ltd.
$
(52,272
)
 
$
(47,336
)
 
$
(21,934
)
 
$
69,267

 
$
(52,275
)

Condensed Consolidating Statements of Operations for the six months ended June 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
306,226

 
$

 
$
306,226

Cost of revenues

 

 
274,403

 

 
274,403

Selling, general and administrative expenses
9,488

 
1,172

 
55,919

 

 
66,579

Restructuring costs

 

 
4,698

 

 
4,698

Operating loss
(9,488
)
 
(1,172
)
 
(28,794
)
 

 
(39,454
)
Interest income
68,089

 
814

 
393

 
(68,883
)
 
413

Interest expense
(49,235
)
 
(58,377
)
 
(24,457
)
 
68,883

 
(63,186
)
Loss on extinguishment of debt
(23,115
)
 

 

 

 
(23,115
)
Foreign currency exchange (loss) / gain, net
(20,656
)
 
636

 
(14,785
)
 

 
(34,805
)
Change in fair value of derivatives

 

 
104

 

 
104

Other expense

 

 
(425
)
 

 
(425
)
Loss from continuing operations before tax and loss on investment in subsidiaries
(34,405
)
 
(58,099
)
 
(67,964
)
 

 
(160,468
)
Credit for income taxes

 
5,574

 
5,739

 

 
11,313

Loss from continuing operations before loss on investment in subsidiaries
(34,405
)
 
(52,525
)
 
(62,225
)
 

 
(149,155
)
Loss on investment in subsidiaries
(123,826
)
 
(71,690
)
 

 
195,516

 

Loss from continuing operations
(158,231
)
 
(124,215
)
 
(62,225
)
 
195,516

 
(149,155
)
Loss from discontinued operations, net of tax

 

 
(896
)
 

 
(896
)
Net loss
(158,231
)
 
(124,215
)
 
(63,121
)
 
195,516

 
(150,051
)
Net loss attributable to noncontrolling interests

 

 
813

 

 
813

Net loss attributable to CME Ltd.
(158,231
)
 
(124,215
)
 
(62,308
)
 
195,516

 
(149,238
)
Comprehensive loss attributable to CME Ltd.
$
(158,231
)
 
$
(123,826
)
 
$
(71,690
)
 
$
195,516

 
$
(158,231
)




Condensed Consolidating Statements of Cash Flows for the six months ended June 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash (used in) / generated from continuing operating activities
$
(16,852
)
 
$
(29,208
)
 
$
29,144

 
$

 
$
(16,916
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(14,199
)
 

 
(14,199
)
Disposal of property, plant and equipment

 

 
145

 

 
145

Intercompany investing receipts
315,249

 
41,186

 

 
(356,435
)
 

Intercompany investing payments
(326,665
)
 
(28,019
)
 

 
354,684

 

Net cash (used in) / provided by continuing investing activities
(11,416
)
 
13,167

 
(14,054
)
 
(1,751
)
 
(14,054
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayment of Senior Debt
(400,673
)
 

 

 

 
(400,673
)
Debt transaction costs
(10,998
)
 

 
(1,594
)
 

 
(12,592
)
Issuance of Senior Debt
221,374

 

 

 

 
221,374

Proceeds from credit facilities
16,801

 

 

 

 
16,801

Payment of credit facilities and capital leases

 

 
(749
)
 

 
(749
)
Issuance of common stock warrants

191,825

 

 

 

 
191,825

Dividends paid to holders of noncontrolling interests

 

 
(46
)
 

 
(46
)
Intercompany financing receipts

 
326,665

 
28,019

 
(354,684
)
 

Intercompany financing payments

 
(315,249
)
 
(41,186
)
 
356,435

 

Net cash provided by / (used in) continuing financing activities
18,329

 
11,416

 
(15,556
)
 
1,751

 
15,940

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(645
)
 

 
(645
)
Net cash used in discontinued operations - financing activities

 

 
(107
)
 

 
(107
)
 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash

 
44

 
(62
)
 

 
(18
)
Net decrease in cash and cash equivalents
(9,939
)
 
(4,581
)
 
(1,280
)
 

 
(15,800
)
CASH AND CASH EQUIVALENTS, beginning of period
19,461

 
5,422

 
78,741

 

 
103,624

CASH AND CASH EQUIVALENTS, end of period
$
9,522

 
$
841

 
$
77,461

 
$

 
$
87,824






Condensed Consolidating Statements of Cash Flows for the six months ended June 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash (used in) / generated from continuing operating activities
$
(45,760
)
 
$
222,511

 
$
(214,001
)
 
$

 
$
(37,250
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(14,808
)
 

 
(14,808
)
Disposal of property, plant and equipment

 

 
264

 

 
264

Intercompany investing receipts
502,771

 
9,323

 

 
(512,094
)
 

Intercompany investing payments
(474,252
)
 
(205,886
)
 

 
680,138

 

Net cash provided by / (used in) continuing investing activities
28,519

 
(196,563
)
 
(14,544
)
 
168,044

 
(14,544
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayment of Senior Debt
(310,322
)
 

 

 

 
(310,322
)
Debt transactions costs
(639
)
 

 
(146
)
 

 
(785
)
Change in restricted cash
20,467

 

 

 

 
20,467

Proceeds from credit facilities

 

 
377

 

 
377

Payment of credit facilities and capital leases

 

 
(876
)
 

 
(876
)
Issuance of common stock
157,116

 

 

 

 
157,116

Issuance of preferred stock
200,000

 

 

 

 
200,000

Equity issuance costs
(4,322
)
 

 

 

 
(4,322
)
Dividends paid to holders of noncontrolling interests

 

 
(184
)
 

 
(184
)
Intercompany financing receipts

 
474,252

 
205,886

 
(680,138
)
 

Intercompany financing payments


 
(502,771
)
 
(9,323
)
 
512,094

 

Net cash provided by / (used in) financing activities
62,300

 
(28,519
)
 
195,734

 
(168,044
)
 
61,471

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(1,053
)
 

 
(1,053
)
Net cash provided by discontinued operations - financing activities

 

 
67

 

 
67

 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash

 
27

 
(3,504
)
 

 
(3,477
)
Net increase / (decrease) in cash and cash equivalents
45,059

 
(2,544
)
 
(37,301
)
 

 
5,214

CASH AND CASH EQUIVALENTS, beginning of period
9,372

 
2,836

 
126,471

 

 
138,679

CASH AND CASH EQUIVALENTS, end of period
$
54,431

 
$
292

 
$
89,170

 
$

 
$
143,893